eXRD/USDT Buy (D1-W1)
Updated
Radix. Strong fundamentals. Layer-1 infrastructure project.
FA.
Strength:
1/ L1-projects narrative.
Radix stands out against "Layer 1 solution" landscape. Fundamental research over 8+ years. Great team.
2/ Tech fundamentals
- Vitalik's trilemma solved (security, scalability and decentralisation)
- composability (dApps are building blocks of DeFi, more complex features/apps can emerge on top of only seamlessly interconnected dApps sets. Analogue from PC era: Semiconductor = dApp, Integrated Circuit = dApps "Lego set"
- easy-to-use tools compared to competitors (easy native language & blueprints to build dApps. But DYOR, I'm not a dev)
3/ Future significant releases/roadmap milestones (major Radix features are yet to come to light)
4/ Strong and dedicated community
5/ In terms of benchmarks/evaluation ratios, XRD has a decent room to grow to meet L-1 project's evaluation (mcap)
Weakness:
1/ low liquidity/still not on major CEXs (Coinbase, Binance...)
2/ no "triple A" funds on board (but the other side - opportunity to get some XRD at a great Risk/Reward level)
TA + PA.
1/ TA doesn't look great tbh, but take a look at 15 Sept event (full unlock). There was a dump from only 1 whale (probably it was a mistake) of 15 mln eXRD on UniSwap which was completely bought out within 2-3 min.
2/ Since 15 Sept we haven't witnessed any significant sells after full unlock. Only slow bleeding on declining volumes. Community dedication confirmed.
3/ 1st and the last resistance - 0.17. Then - price discovery.
Entry: 1st - 0.095-0.11, 2nd - 0.085-0.095
Stop: HODL or below 0.08 with confirmation on W1
Target: 1st - $1 (x10)
Disclaimer:
Strongly advise to DYOR Radix project and tech details! There's a lot of educational stuff on their website regarding DLT technology and L1 solutions.
And yes, I hold a bag of XRD.
FA.
Strength:
1/ L1-projects narrative.
Radix stands out against "Layer 1 solution" landscape. Fundamental research over 8+ years. Great team.
2/ Tech fundamentals
- Vitalik's trilemma solved (security, scalability and decentralisation)
- composability (dApps are building blocks of DeFi, more complex features/apps can emerge on top of only seamlessly interconnected dApps sets. Analogue from PC era: Semiconductor = dApp, Integrated Circuit = dApps "Lego set"
- easy-to-use tools compared to competitors (easy native language & blueprints to build dApps. But DYOR, I'm not a dev)
3/ Future significant releases/roadmap milestones (major Radix features are yet to come to light)
4/ Strong and dedicated community
5/ In terms of benchmarks/evaluation ratios, XRD has a decent room to grow to meet L-1 project's evaluation (mcap)
Weakness:
1/ low liquidity/still not on major CEXs (Coinbase, Binance...)
2/ no "triple A" funds on board (but the other side - opportunity to get some XRD at a great Risk/Reward level)
TA + PA.
1/ TA doesn't look great tbh, but take a look at 15 Sept event (full unlock). There was a dump from only 1 whale (probably it was a mistake) of 15 mln eXRD on UniSwap which was completely bought out within 2-3 min.
2/ Since 15 Sept we haven't witnessed any significant sells after full unlock. Only slow bleeding on declining volumes. Community dedication confirmed.
3/ 1st and the last resistance - 0.17. Then - price discovery.
Entry: 1st - 0.095-0.11, 2nd - 0.085-0.095
Stop: HODL or below 0.08 with confirmation on W1
Target: 1st - $1 (x10)
Disclaimer:
Strongly advise to DYOR Radix project and tech details! There's a lot of educational stuff on their website regarding DLT technology and L1 solutions.
And yes, I hold a bag of XRD.
Note
Oct, 21: breaking up diag resistance. Wide-spread green candle on decent volume straight from $0.097-0.1Good buying opportunity in 0.113-0.118 zone (retest of diag support/resistance)
Note
Approaching the first and the last resistance ($0.17-18 range) on the way up...Trade active
wowNote
wen $1 sir?Trade active
Continuation pattern detected: breaking up diag resistance. Waiting for retest...
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.